Cargando…
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden cardiac death among patients with persistently reduced (≤35 %) left ventricular ejection fraction (LVEF) at least 40 days following acute myocardial infarction (AMI). Few prior studies have used LVEF measured after...
Autores principales: | Judson, Gregory L., Cohen, Beth E., Muniyappa, Anoop, Raitt, Merritt H., Shen, Hui, Tarasovsky, Gary, Whooley, Mary A., Dhruva, Sanket S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601204/ https://www.ncbi.nlm.nih.gov/pubmed/37886349 http://dx.doi.org/10.1016/j.ahjo.2022.100186 |
Ejemplares similares
-
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017) -
Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023) -
Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010) -
Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023) -
Same-day Subcutaneous Implantable Cardioverter-defibrillator Placement and Discharge: Another Step Toward Outpatient Electrophysiology
por: Ellis, Christopher R.
Publicado: (2020)